Wednesday, August 5, 2020

Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drug

Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drug In a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP in the strengths of 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20 mg.

from Moneycontrol Business News https://ift.tt/31mOuo9
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Sensex, Nifty slip 0.7% as Fed’s cautious outlook damps investor sentiment

Indian stock markets experienced a decline on Thursday. The NSE Nifty and BSE Sensex closed lower. This downturn followed the US Federal Res...